[
    [
        {
            "time": "2020-12-10",
            "original_text": "Lilly's (LLY) Tirzepatide Meets Endpoints in Late-Stage Study",
            "features": {
                "keywords": [
                    "Tirzepatide",
                    "Endpoints",
                    "Late-Stage",
                    "Study"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly's (LLY) Tirzepatide Meets Endpoints in Late-Stage Study",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-10",
            "original_text": "Thiel-backed antibody therapy developer AbCellera boosts IPO price range",
            "features": {
                "keywords": [
                    "Thiel-backed",
                    "antibody",
                    "therapy",
                    "developer",
                    "AbCellera",
                    "IPO",
                    "price",
                    "range"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Thiel-backed antibody therapy developer AbCellera boosts IPO price range",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-10",
            "original_text": "Eli Lilly (LLY) Soars: Stock Adds 5.8% in Session",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Soars",
                    "Stock",
                    "Adds",
                    "5.8%",
                    "Session"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Soars: Stock Adds 5.8% in Session",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]